Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients

Saved in:

Bibliographic Details
Published in:	Journal of neurology Vol. 260; no. 1; pp. 327 - 329
Main Authors:	Ghezzi, A., Rocca, M. A., Baroncini, D., Annovazzi, P., Zaffaroni, M., Minonzio, G., Comi, G., Filippi, M.
Format:	Journal Article
Language:	English
Published:	Berlin/Heidelberg Springer-Verlag 2013 Springer Nature B.V
Subjects:	Adult Disability Evaluation Female Fingolimod Hydrochloride Humans Immunosuppressive Agents - administration & dosage Letter to the Editors Magnetic Resonance Imaging Medicine Medicine & Public Health Middle Aged Multiple sclerosis Multiple Sclerosis - drug therapy Neurology Neuroradiology Neurosciences Propylene Glycols - administration & dosage Recurrence Sphingosine - administration & dosage Sphingosine - analogs & derivatives Substance Withdrawal Syndrome - drug therapy Substance Withdrawal Syndrome - etiology Multiple Sclerosis Human Papilloma Virus Natalizumab Brain Magnetic Resonance Imaging Levetiracetam
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0340-5354 1432-1459
DOI:	10.1007/s00415-012-6744-7